Trial NCT03477864

View at ClinicalTrials.gov 
Org. Study IDs: 17G.508

Last trial update was posted on 2019-11-12

MeSH Interventions

Antibodies Antibodies, Monoclonal Antineoplastic Agents, Immunological Cemiplimab Immunoglobulins Ipilimumab

MeSH Conditions

Prostatic Neoplasms

Other Conditions

Stage III Prostate Cancer Stage IIIA Prostate Cancer Stage IIIB Prostate Cancer Stage IIIC Prostate Cancer Stage IV Prostate Cancer Stage IVA Prostate Cancer Stage IVB Prostate Cancer

Stopping Reasons

Study was not accruing

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID